ARS-1

· ARS Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ARS-1, covering 2024-07-30 to 2026-07-14. Get the full timeline:

Most recent: Clinical Trial Results: Administration of ARS-1 or Albuterol in Subjects With Persistent Asthma [Phase 2]